B. Farisoğulları Et Al. , "Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.," Clinical and experimental rheumatology , vol.40, pp.112-119, 2022
Farisoğulları, B. Et Al. 2022. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.. Clinical and experimental rheumatology , vol.40 , 112-119.
Farisoğulları, B., Yardımcı, G. K., Sarı, A., Bilgin, E., Bölek, E. Ç., Duran, E., ... Kılıç, L.(2022). Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.. Clinical and experimental rheumatology , vol.40, 112-119.
Farisoğulları, Bayram Et Al. "Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.," Clinical and experimental rheumatology , vol.40, 112-119, 2022
Farisoğulları, Bayram Et Al. "Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.." Clinical and experimental rheumatology , vol.40, pp.112-119, 2022
Farisoğulları, B. Et Al. (2022) . "Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.." Clinical and experimental rheumatology , vol.40, pp.112-119.
@article{article, author={Bayram Farisoğulları Et Al. }, title={Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.}, journal={Clinical and experimental rheumatology}, year=2022, pages={112-119} }